Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Long Hoang Dao"'
Autor:
Qingnan Zhao, Jiemiao Hu, Lingyuan Kong, Shan Jiang, Xiangjun Tian, Jing Wang, Rintaro Hashizume, Zhiliang Jia, Natalie Wall Fowlkes, Jun Yan, Xueqing Xia, Sofia F. Yi, Long Hoang Dao, David Masopust, Amy B. Heimberger, Shulin Li
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Glioblastoma is an aggressive type of cancer with poor patient prognosis. Here, the authors show that T cells armed with an FGL2-specific scFV can induce antitumour responses mediated by tissue-resident memory T cells in the brain.
Externí odkaz:
https://doaj.org/article/a82f40cd9e5e4bbf9d2fef575b4df240
Autor:
Shulin Li, Richard Gorlick, Xueqing Xia, Sheng Zhang, Wendong Zhang, Long Hoang Dao, Jing Wang, Qi Wang, Zhiliang Jia, Jiemiao Hu, Qing Yang
Supplementary Figure from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ffeee0becd2e714b15c8525a23014cc
https://doi.org/10.1158/1078-0432.22486535
https://doi.org/10.1158/1078-0432.22486535
Autor:
Shulin Li, Richard Gorlick, Xueqing Xia, Sheng Zhang, Wendong Zhang, Long Hoang Dao, Jing Wang, Qi Wang, Zhiliang Jia, Jiemiao Hu, Qing Yang
Purpose:Chimeric antigen receptor (CAR) T-cell therapy has shown great promise for treating hematologic malignancies but requires a long duration of T-cell expansion, is associated with severe toxicity, and has limited efficacy for treating solid tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95949e8db4d0799b419c6f99f4a435db
https://doi.org/10.1158/1078-0432.c.6532343
https://doi.org/10.1158/1078-0432.c.6532343
Autor:
Qing Yang, Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Hoang Dao, Wendong Zhang, Sheng Zhang, Xueqing Xia, Richard Gorlick, Shulin Li
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(17)
Purpose: Chimeric antigen receptor (CAR) T-cell therapy has shown great promise for treating hematologic malignancies but requires a long duration of T-cell expansion, is associated with severe toxicity, and has limited efficacy for treating solid tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7bd63216429fd41d2eac8dcf01d46d
https://pubmed.ncbi.nlm.nih.gov/35727602
https://pubmed.ncbi.nlm.nih.gov/35727602